Layer 1

MHRA: Be cautious of mislabelled pregabalin

MHRA: The affected batch has not been recalled to maintain "continuity of supply"

Some blister packs of the epilepsy drug are labelled as 25mg as well as the correct strength of 75mg, says the MHRA

Pharmacists should be “cautious” when using pregabalin capsules labelled with the incorrect strength, the Medicines and Healthcare products Regulatory Authority (MHRA) has warned.

The “majority of cartons” from one batch of the epilepsy drug are likely to contain "one or two" blisters labelled as both 25mg and 75mg, the medicines watchdog said yesterday (August 12).

Teva notified the MHRA about the printing error, which means that affected blister packs have the incorrect strength of 25mg printed in one position. The correct strength is still printed on other parts of the packs as well as on their carton labels and information leaflet, the MHRA stressed.

The stock has not been recalled “to ensure continuity of supply”, it said. “However, no further stock with this error will be released to the market,” the MHRA added.

General enquiries about the error should be directed to Teva UK’s customer service team on 0800 590502. Medical queries should be directed to Teva UK on 0207 5407117 or [email protected].

Affected batch:

Batch number

Expiry date

Pack size

First distributed


December 2017

1 X 56

July 15, 2015


Do you have any packs from the affected batch?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Login or register to post comments

Job of the week

Support Pharmacist
Queen Elizabeth Hospital and Heartl
up to £47,500 dependent on hours (30-40 hours flexible)